TrimRX
US$ 26.60
iih glp 1 Metabolic pathogenesis and treatment in IIH. is most prevalent in GLP-1 medications and pseudotumor cerebri
Description
[1] [2] The medication works through a novel mechanism of action as a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist
J Clin Neurosci
Tirzepatide combined with mirikizumab (Omvoh) is being evaluated in Phase 3 trials for adults with ulcerative colitis (UC) or Crohns disease (CD)completion of these studies are expected in 2028
Whey protein also supports gut microbiome for immune system support and nutrient absorption
Available at: (Accessed August 9, 2022)
